Systematic approach crucial for person-centred care

Systematic efforts and a clear structure are decisive factors in the transition to person-centred health care. A University of Gothenburg study, published in the scientific journal BMJ, reflects what is now a decade of experience and research in the field.

Expectations are growing stronger for health care to be person-centered, and therefore emanate from a partnership between staff, patients and relatives. But at the same times, the process of introducing and maintaining this way of working is slow and laborious in many places.

We already know that person-centred care can shorten hospital stay and reduce uncertainty in health care. Now, instead, we need to concentrate on how to achieve it, the researchers behind the broad BMJ article argue.

The study offers advice and tools for further research on, and development of, person-centred care. The corresponding author is Axel Wolf, Associate Professor of Health Care Sciences at the Institute of Health and Care Sciences at the Sahlgrenska Academy, University of Gothenburg. Axel Wolf is also affiliated to the University of Gothenburg Centre for Person-centred Care (GPCC).

“One of the key pieces of advice is that person-centred care must be practiced systematically on an everyday basis. This entails creating the organisational and individual conditions for developing a partnership between the patient, the patient’s relatives if applicable, and the staff at every meeting — not just when it fits into the schedule,” Wolf says.

“To achieve the best clinical effect, it is important for person-centred care not to be just a matter between the patient and the individual professional representative. It has to permeate the whole organisation. There is also a big challenge involved in increasing the understanding of how person-centred care differs from current care practice.”

It is fundamental for health care professionals to take the time to listen to what patients have experienced and wants to achieve in relation to their health. They must let the patient’s goals, such as returning to work or being able to take a walk, guide the wording of a jointly agreed health plan. The patient’s priorities and resources must be reflected in the health-plan, which must also be subject to continuous evaluation. The documentation must then accompany and be accessible to the patient, and this includes any move from hospital to primary care or municipal social care.

Since it set out ten years ago GPCC, a national research centre, has led the way in developing, testing, evaluating and implementing person-centred care in many different health care contexts, in Sweden and abroad.

Together with his colleague Professor Nicky Britten of the University of Exeter in England, Axel Wolf has lead an international research group investigating the enablers and the obstacles experienced by researchers, clinicians, and patients during clinical studies within the GPCC framework, and in everyday implementation of research results.

Among the obstacles described in the current study are hierarchical care structures, rigid occupational roles, and the conviction that one is already working in a person-centred way.

“With the current shift in Swedish health care to “good quality local health care,” which is permeated by person-centred principles, the ethical approach focusing on the person and not only the diagnosis must be practiced constantly to optimize conditions. This requires systematic education and training, lifelong learning, and tools that facilitate the partnership,” Axel Wolf concludes.

Story Source:

Materials provided by University of Gothenburg. Note: Content may be edited for style and length.

Share Button

High-precision electrochemistry: The new gold standard in fuel cell catalyst development

Vehicles powered by polymer electrolyte membrane fuel cells (PEMFCs) are energy-efficient and eco-friendly, but despite increasing public interest in PEMFC-powered transportation, current performance of materials that are used in fuel cells limits their widespread commercialization.

Scientists at the U.S. Department of Energy’s (DOE) Argonne National Laboratory led a team to investigate reactions in PEMFCs, and their discoveries informed the creation of technology that could bring fuel cells one step closer to realizing their full market potential.

PEMFCs rely on hydrogen as a fuel, which is oxidized on the cell’s anode side through a hydrogen oxidation reaction, while oxygen from the air is used for an oxygen reduction reaction (ORR) at the cathode. Through these processes, fuel cells produce electricity to power electric motors in vehicles and other applications, emitting water as the only by-product.

Platinum-based, nano-sized particles are the most effective materials for promoting reactions in fuel cells, including the ORR in the cathode. However, in addition to their high cost, platinum nanoparticles suffer from gradual degradation, especially in the cathode, which limits catalytic performance and reduces the lifetime of the fuel cell.

The research team, which included DOE’s Oak Ridge National Laboratory and several university partners, used a novel approach to examine dissolution processes of platinum at the atomic and molecular level. The investigation enabled them to identify the degradation mechanism during the cathodic ORR, and the insights guided the design of a nanocatalyst that uses gold to eliminate platinum dissolution.

“The dissolution of platinum occurs at the atomic and molecular scale during exposure to the highly corrosive environment in fuel cells,” said Vojislav Stamenkovic, a senior scientist and group leader for the Energy Conversion and Storage group in Argonne’s Materials Science Division (MSD). “This material degradation affects the fuel cell’s long-term operations, presenting an obstacle for fuel cell implementation in transportation, specifically in heavy duty applications such as long-haul trucks.”

Starting small

The scientists used a range of customized characterization tools to investigate the dissolution of well-defined platinum structures in single-crystal surfaces, thin films and nanoparticles.

“We have developed capabilities to observe processes at the atomic scale to understand the mechanisms responsible for dissolution and to identify the conditions under which it occurs,” said Pietro Papa Lopes, a scientist in Argonne’s MSD and first author on the study. “Then we implemented this knowledge into material design to mitigate dissolution and increase durability.”

The team studied the nature of dissolution at the fundamental level using surface-specific tools, electrochemical methods, inductively coupled plasma mass spectrometry, computational modeling and atomic force, scanning tunneling and high-resolution transmission microscopies.

In addition, the scientists relied on a high-precision synthesis approach to create structures with well-defined physical and chemical properties, ensuring that the relationships between structure and stability discovered from studying 2D surfaces were carried over to the 3D nanoparticles they produced.

“We performed these studies — from single crystals, to thin films, to nanoparticles — which showed us how to synthesize platinum catalysts to increase durability,” said Lopes, “and by looking at these different materials, we also identified strategies for using gold to protect the platinum.”

Going for gold

As the scientists uncovered the fundamental nature of dissolution by observing its occurrence in several testbed scenarios, the team used the knowledge to mitigate dissolution with the addition of gold.

The researchers used transmission electron microscopy capabilities at Argonne’s Center for Nanoscale Materials and at the Center for Nanophase Materials Sciences at Oak Ridge National Laboratory — both DOE Office of Science User Facilities — to image platinum nanoparticles after synthesis and before and after operation. This technique allowed the scientists to compare the stability of the nanoparticles with and without incorporated gold.

The team found that controlled placement of gold in the core promotes the arrangement of platinum in an optimal surface structure that grants high stability. In addition, gold was selectively deposited on the surface to protect specific sites that the team identified as particularly vulnerable for dissolution. This strategy eliminates dissolution of platinum from even the smallest nanoparticles used in this study by keeping platinum atoms attached to the sites where they can still effectively catalyze the ORR.

Atomic-level understanding

Understanding the mechanisms behind dissolution at the atomic level is essential to uncovering the correlation between platinum loss, surface structure and size and ratio of platinum nanoparticles, and determining how these relationships affect long-term operation.

“The novel part of this research is resolving the mechanisms and fully mitigating platinum dissolution by material design at different scales, from single crystals and thin films to nanoparticles,” said Stamenkovic. “It’s the insights we gained in conjunction with the design and synthesis of a nanomaterial that addresses durability issues in fuel cells, as well as the ability to delineate and quantify dissolution of platinum catalyst from other processes that contribute to fuel cell performance decay.”

The team is also developing a predictive aging algorithm to assess the long-term durability of the platinum-based nanoparticles and found a 30-fold improvement in durability compared to nanoparticles without gold.

Share Button

Contraceptive services ‘even worse’ after coronavirus

The coronavirus has made a “difficult situation even worse” for women, says a group of MPs.

Share Button

Your Most Valuable Minutes

Please enter your name.

Please enter a valid email address.

Thanks for requesting the One-Minute Productivity Hacks PDF. To receive your download link, please click the confirmation link in the email that has been sent to you.

Something went wrong. Please check your entries and try again.

Share Button

Coronavirus: Long waits for hospital operations soar in England

More than two million people on the waiting list in England have been waiting more than 18 weeks.

Share Button

Coronavirus: Concerns over Boris Johnson’s ‘moonshot’ testing plans

Medical experts raise doubts about plans to have “millions” of coronavirus tests processed every day.

Share Button

Health24.com | Sleep problems in early childhood linked to teens’ mental health issues

  • A number of sleep problems in childhood can point towards psychological problems in adolescence
  • For example, less sleep at night and going to bed later is associated with borderline personality disorder
  • Sleep can, however, be influenced with effective, early interventions

Teens who had sleep problems as babies or tots may be at risk for mental health disorders, a new study suggests.

Researchers analysed data from more than 13 000 people who were part of a British study in the 1990s. Their parents reported their sleep behaviour six times between the ages of six months and 5.8 years.

Those who had irregular sleep routines from six months on and who often woke at night at 18 months of age were more likely to experience psychotic episodes as teens, the study found.

Problems in adolescence

Getting less sleep at night and going to bed later at age 3.5 was associated with borderline personality disorder during adolescence, according to the University of Birmingham study published in the journal JAMA Psychiatry.

“We know from previous research that persistent nightmares in children have been associated with both psychosis and borderline personality disorder. But nightmares do not tell the whole story – we’ve found that, in fact, a number of behavioural sleep problems in childhood can point towards these problems in adolescence,” said lead researcher Isabel Morales-Muñoz, an honorary research fellow at the university.

Senior author Steven Marwaha, a professor of psychiatry, said brain and hormone changes make adolescence a key period for studying the onset of mental disorders.

“It’s crucial to identify risk factors that might increase the vulnerability of adolescents to the development of these disorders, identify those at high risk, and deliver effective interventions,” he said, adding that the study helps explain what those risk factors might be.

“Sleep may be one of the most important underlying factors – and it’s one that we can influence with effective, early interventions, so it’s important that we understand these links,” Marwaha said.

Image credit: iStock

Share Button

Health24.com | Could Viagra, Cialis help boost colon cancer survival?

  • ED medication may reduce the risk of death in men who suffer from colorectal cancer 
  • The reason why the drugs have an anti-tumour effect isn’t yet clear
  • However, according to an expert, they are known to block a protein that may play a role in cancer development

Erectile dysfunction (ED) drugs such as Viagra, Cialis and Levitra may do more than restore sexual function – they may also prolong the lives of men with colon cancer.

That’s the conclusion of a new Swedish study, which reported that the risk of premature death dropped by as much as 18% among colon cancer patients who used ED drugs.

The medications were also linked to a 15% reduction in risk for the key cause of death from colon cancer – that is, cancer that has spread.

“This is the first population-based study to explore the effect of these drugs on the death risk in men with colorectal cancer,” said lead author Wuqing Huang, a doctoral candidate at Lund University in Sweden.

Cancer-fighting potential

She and her colleagues focused on so-called “PDE5 inhibitors” – drugs that address impotence by regulating penile blood flow.

“There are two reasons why we considered the anti-cancer possibility of these drugs,” Huang said.

Prior studies suggested that ED drugs can inhibit tumour growth in mice and the activity of a gene called PDE5A. Huang said past work suggested colon cancer patients with lower PDE5A activity levels may live “significantly longer” than others.

To get a better handle on the cancer-fighting potential of the drugs, the researchers used a nationwide database to identify men in Sweden who were diagnosed with colon cancer between 2005 and 2014.

After excluding patients with late-stage cancer, researchers focused on more than 11 300 cancer patients who were not taking an ED drug and about 1 100 patients who were. (No one was instructed to use the drugs if they weren’t already doing so.)

Over more than four years of follow-up, about 10% of those who used an ED drug died, compared to 17.5% of patients who did not. The risk was even lower for those in the ED group who also had cancer surgery.

An observational study

Huang said the explanation for the drugs’ anti-tumour effect isn’t yet clear. It could have to do with the beneficial impact EDs have on immune function, reduced cell death and chemotherapy sensitivity, she said.

But until researchers can get a better understanding, “it is not suggested for colon cancer patients to get ED medications to control their cancer at this moment,” Huang said.

“The current evidence is not enough to provide recommendations, as our study is an observational study,” she stressed. “Clinical trials are necessary to confirm it.”

Still, Dr Andrew Chan, a professor at Harvard Medical School and Massachusetts General Hospital in Boston who reviewed the study, said the findings were intriguing.

“The work extends a prior study from this group showing that these medications may reduce the risk of developing colorectal cancer,” he noted. “It is also biologically plausible that these medications may have an anti-cancer effect, since they are known to block a specific protein that may play a role in cancer development.”

The findings were recently published in the journal Nature Communications.

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Designed antiviral proteins inhibit SARS-CoV-2 in the lab

Computer-designed small proteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19.

The findings are reported today, Sept. 9, in Science

In the experiments, the lead antiviral candidate, named LCB1, rivaled the best-known SARS-CoV-2 neutralizing antibodies in its protective actions. LCB1 is currently being evaluated in rodents.

Coronaviruses are studded with so-called Spike proteins. These latch onto human cells to enable the virus to break in and infect them. The development of drugs that interfere with this entry mechanism could lead to treatment of or even prevention of infection.

Institute for Protein Design researchers at the University of Washington School of Medicine used computers to originate new proteins that bind tightly to SARS-CoV-2 Spike protein and obstruct it from infecting cells.

Beginning in January, more than two million candidate Spike-binding proteins were designed on the computer. Over 118,000 were then produced and tested in the lab.

“Although extensive clinical testing is still needed, we believe the best of these computer-generated antivirals are quite promising,” said lead author Longxing Cao, a postdoctoral scholar at the Institute for Protein Design.

“They appear to block SARS-CoV-2 infection at least as well as monoclonal antibodies, but are much easier to produce and far more stable, potentially eliminating the need for refrigeration,” he added.

The researchers created antiviral proteins through two approaches. First, a segment of the ACE2 receptor, which SARS-CoV-2 naturally binds to on the surface of human cells, was incorporated into a series of small protein scaffolds.

Second, completely synthetic proteins were designed from scratch. The latter method produced the most potent antivirals, including LCB1, which is roughly six times more potent on a per mass basis than the most effective monoclonal antibodies reported thus far.

Scientists from the University of Washington School of Medicine in Seattle and Washington University School of Medicine in St. Louis collaborated on this work.

“Our success in designing high-affinity antiviral proteins from scratch is further proof that computational protein design can be used to create promising drug candidates,” said senior author and Howard Hughes Medical Institute Investigator David Baker, professor of biochemistry at the UW School of Medicine and head of the Institute for Protein Design. In 2019, Baker gave a TED talk on how protein design might be used to stop viruses.

To confirm that the new antiviral proteins attached to the coronavirus Spike protein as intended, the team collected snapshots of the two molecules interacting by using cryo-electron microscopy. These experiments were performed by researchers in the laboratories of David Veesler, assistant professor of biochemistry at the UW School of Medicine, and Michael S. Diamond, the Herbert S. Gasser Professor in the Division of Infectious Diseases at Washington University School of Medicine in St. Louis.

“The hyperstable minibinders provide promising starting points for new SARS-CoV-2 therapeutics,” the antiviral research team wrote in their study pre-print, “and illustrate the power of computational protein design for rapidly generating potential therapeutic candidates against pandemic threats.”

Story Source:

Materials provided by University of Washington Health Sciences/UW Medicine. Original written by Ian Haydon, Institute for Protein Design. Note: Content may be edited for style and length.

Share Button

Seeing objects through clouds and fog

Like a comic book come to life, researchers at Stanford University have developed a kind of X-ray vision — only without the X-rays. Working with hardware similar to what enables autonomous cars to “see” the world around them, the researchers enhanced their system with a highly efficient algorithm that can reconstruct three-dimensional hidden scenes based on the movement of individual particles of light, or photons. In tests, detailed in a paper published Sept. 9 in Nature Communications, their system successfully reconstructed shapes obscured by 1-inch-thick foam. To the human eye, it’s like seeing through walls.

“A lot of imaging techniques make images look a little bit better, a little bit less noisy, but this is really something where we make the invisible visible,” said Gordon Wetzstein, assistant professor of electrical engineering at Stanford and senior author of the paper. “This is really pushing the frontier of what may be possible with any kind of sensing system. It’s like superhuman vision.”

This technique complements other vision systems that can see through barriers on the microscopic scale — for applications in medicine — because it’s more focused on large-scale situations, such as navigating self-driving cars in fog or heavy rain and satellite imaging of the surface of Earth and other planets through hazy atmosphere.

Supersight from scattered light

In order to see through environments that scatter light every-which-way, the system pairs a laser with a super-sensitive photon detector that records every bit of laser light that hits it. As the laser scans an obstruction like a wall of foam, an occasional photon will manage to pass through the foam, hit the objects hidden behind it and pass back through the foam to reach the detector. The algorithm-supported software then uses those few photons — and information about where and when they hit the detector — to reconstruct the hidden objects in 3D.

This is not the first system with the ability to reveal hidden objects through scattering environments, but it circumvents limitations associated with other techniques. For example, some require knowledge about how far away the object of interest is. It is also common that these systems only use information from ballistic photons, which are photons that travel to and from the hidden object through the scattering field but without actually scattering along the way.

“We were interested in being able to image through scattering media without these assumptions and to collect all the photons that have been scattered to reconstruct the image,” said David Lindell, a graduate student in electrical engineering and lead author of the paper. “This makes our system especially useful for large-scale applications, where there would be very few ballistic photons.”

In order to make their algorithm amenable to the complexities of scattering, the researchers had to closely co-design their hardware and software, although the hardware components they used are only slightly more advanced than what is currently found in autonomous cars. Depending on the brightness of the hidden objects, scanning in their tests took anywhere from one minute to one hour, but the algorithm reconstructed the obscured scene in real-time and could be run on a laptop.

“You couldn’t see through the foam with your own eyes, and even just looking at the photon measurements from the detector, you really don’t see anything,” said Lindell. “But, with just a handful of photons, the reconstruction algorithm can expose these objects — and you can see not only what they look like, but where they are in 3D space.”

Space and fog

Someday, a descendant of this system could be sent through space to other planets and moons to help see through icy clouds to deeper layers and surfaces. In the nearer term, the researchers would like to experiment with different scattering environments to simulate other circumstances where this technology could be useful.

“We’re excited to push this further with other types of scattering geometries,” said Lindell. “So, not just objects hidden behind a thick slab of material but objects that are embedded in densely scattering material, which would be like seeing an object that’s surrounded by fog.”

Lindell and Wetzstein are also enthusiastic about how this work represents a deeply interdisciplinary intersection of science and engineering.

“These sensing systems are devices with lasers, detectors and advanced algorithms, which puts them in an interdisciplinary research area between hardware and physics and applied math,” said Wetzstein. “All of those are critical, core fields in this work and that’s what’s the most exciting for me.”

Story Source:

Materials provided by Stanford University. Original written by Taylor Kubota. Note: Content may be edited for style and length.

Share Button